Mechanism of Blood Clotting

Hemostasis: How Your Body Stops Bleeding 

Hemostasis (not to be confused with homeostasis) is the rapid, localized, and well‑controlled process that stops bleeding after vessel injury. It has three coordinated acts:

  1. Vascular spasm
  2. Platelet plug formation
  3. Coagulation (blood clotting)

When successful, hemostasis prevents hemorrhage from small vessels; large‑vessel bleeds often need medical help.

1) Vascular spasm

What happens: Injury to an artery/arteriole makes its circular smooth muscle constrict.

Why it helps: Narrows the lumen, immediately reducing blood loss for minutes to hours.

Triggers: Direct smooth‑muscle damage, pain receptor reflexes, and substances released from activated platelets (e.g., serotonin, thromboxane A2).

2) Platelet plug formation

Platelets are tiny but chemically well‑armed. Their granules store clotting factors, ADP, ATP, Ca2+, serotonin, enzymes to make thromboxane A2, fibrin‑stabilizing factor (XIII), lysosomes, mitochondria, membrane systems for Ca2+ handling, glycogen, and PDGF (platelet‑derived growth factor) for vessel repair.

Stepwise sequence:


Platelet adhesion: Platelets stick to exposed subendothelial collagen at the injury site.

Platelet release reaction: Adherent platelets activate, extend projections, and discharge granule contents.

ADP and thromboxane A2 activate nearby platelets.

Serotonin and thromboxane A2 cause vasoconstriction, sustaining the spasm.

Platelet aggregation: ADP makes platelets “sticky,” so they pile onto one another and build a platelet plug.

Reinforcement: During coagulation, fibrin threads weave through the plug and tighten it, making it effective for small vessel injuries.

PDGF from platelets promotes the proliferation of endothelial cells, smooth muscle, and fibroblasts to repair the wall.

3) Coagulation (blood clotting)

Definitions: Drawn blood forms a gel (clot) that traps cells in a fibrin network; the remaining liquid is serum (plasma minus clotting proteins).

Purpose: Convert soluble fibrinogen into insoluble fibrin strands.

Players: Ca2+, liver‑derived inactive zymogens (clotting factors, named by Roman numerals), platelet and tissue phospholipids.

Three stages:


Formation of prothrombinase

  • Extrinsic pathway (seconds; “outside cue”): Tissue factor (TF, thromboplastin) from damaged tissues + Ca2+ → activates X → Xa + factor V + Ca2+ → prothrombinase.
  • Intrinsic pathway (minutes; “inside cue”): Contact of blood with collagen/rough endothelium and platelet damage → XII activation → cascade to X → Xa + V + Ca2+ → prothrombinase.

Prothrombinase + Ca2+ converts prothrombin → thrombin.

Thrombin + Ca2+ converts fibrinogen → fibrin threads; thrombin also activates factor XIII, stabilizing and strengthening fibrin.

Positive feedback by thrombin:

  • Accelerates prothrombinase formation (via factor V).
  • Activates platelets, reinforcing aggregation and phospholipid release.

Clot retraction

Platelets pull on fibrin strands to tighten and shrink the clot, drawing wound edges together. Serum seeps out, but cells remain trapped. Adequate platelets and factor XIII help stabilize the clot. Fibroblasts and endothelial cells then restore the vessel.

Vitamin K: the clotting cofactor maker

  • Required by the liver to synthesize several clotting factors.
  • Fat‑soluble; depends on normal lipid absorption and bile flow; gut bacteria also produce it.
  • Deficiency (e.g., fat malabsorption, obstructed bile) → bleeding tendency.

Keeping clots in check: fibrinolysis and natural anticoagulants

  • Fibrinolytic system: Plasminogen (built into the clot) → plasmin via thrombin, XIIa, and tissue plasminogen activator (t‑PA) from endothelium.
    • Plasmin digests fibrin and inactivates fibrinogen, prothrombin, and factors V and XII → dissolves clots (fibrinolysis).
  • Why clots stay local:
    • Fibrin binds and sequesters thrombin within the clot.
    • Flow dilutes clotting factors away from the site.
    • Endothelium produces prostacyclin, a strong inhibitor of platelet adhesion and release.
  • Endogenous anticoagulants:
    • Antithrombin (blocks IIa, Xa, XIIa, etc.); heparin from mast cells/basophils boosts antithrombin.
    • Activated protein C (APC) inactivates key cofactors Va and VIIIa and promotes plasminogen activation.

When clotting goes wrong: intravascular clots

Thrombosis: A Clot forms in an intact vessel (often a vein). Causes include roughened endothelium (atherosclerosis, trauma, infection) and stasis (slow flow), which allow local buildup of factors.

Thrombus: The actual intravascular clot.

Embolus: A traveling intravascular mass (clot fragment, air, fat). If it lodges in the lungs → pulmonary embolism; in systemic arteries → downstream ischemia.

Clinical pearls (exam‑friendly)

Aspirin lowers thromboxane A2 synthesis → impairs platelet aggregation.

Heparin acts immediately by enhancing antithrombin; warfarin blocks vitamin K–dependent factor synthesis in the liver.

t‑PA is used to lyse acute clots (e.g., selected MI or ischemic stroke) by activating plasminogen.

Rapid recap

Three pillars: spasm → platelet plug → fibrin clot.

Two initiation routes (extrinsic vs intrinsic) converge on prothrombinase.

Thrombin makes fibrin and amplifies its own generation; factor XIII stabilizes the mesh.

Fibrinolysis and endogenous anticoagulants prevent runaway clotting.

Self‑check

What triggers the extrinsic vs intrinsic pathways?

Name the three steps of platelet plug formation.

Which enzyme dissolves fibrin, and how is it generated?

Comments

Popular posts from this blog

Lymphatic System: Lymph

Characteristics and Functions of RBCs, WBCs, and platelets